Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Assets Average (2016 - 2025)

Amicus Therapeutics' Assets Average history spans 15 years, with the latest figure at $909.3 million for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average rose 15.72% year-over-year to $909.3 million, compared with a TTM value of $909.3 million through Dec 2025, up 15.72%, and an annual FY2025 reading of $867.5 million, up 11.0% over the prior year.
  • Assets Average for Q4 2025 was $909.3 million at Amicus Therapeutics, up from $842.1 million in the prior quarter.
  • The five-year high for Assets Average was $930.9 million in Q4 2021, with the low at $712.3 million in Q1 2023.
  • Average Assets Average over 5 years is $798.9 million, with a median of $786.6 million recorded in 2024.
  • Year-over-year, Assets Average fell 20.31% in 2022 and then increased 15.72% in 2025.
  • Tracing FOLD's Assets Average over 5 years: stood at $930.9 million in 2021, then fell by 20.31% to $741.8 million in 2022, then grew by 3.93% to $771.0 million in 2023, then increased by 1.92% to $785.8 million in 2024, then rose by 15.72% to $909.3 million in 2025.
  • Per Business Quant, the three most recent readings for FOLD's Assets Average are $909.3 million (Q4 2025), $842.1 million (Q3 2025), and $802.6 million (Q2 2025).